Next Article in Journal
Marine Bioactives: Pharmacological Properties and Potential Applications against Inflammatory Diseases
Next Article in Special Issue
Preparation and Characterization of O-Acylated Fucosylated Chondroitin Sulfate from Sea Cucumber
Previous Article in Journal
Diatom Derived Polyunsaturated Aldehydes Do Not Structure the Planktonic Microbial Community in a Mesocosm Study
Mar. Drugs 2012, 10(4), 793-811; doi:10.3390/md10040793
Review

Fucanomics and Galactanomics: Marine Distribution, Medicinal Impact, Conceptions, and Challenges

Received: 21 February 2012; in revised form: 21 March 2012 / Accepted: 22 March 2012 / Published: 29 March 2012
(This article belongs to the Special Issue Marine Glycoconjugates)
View Full-Text   |   Download PDF [222 KB, updated 24 April 2012; original version uploaded 29 March 2012]
Abstract: Glycomics turned out to be a very extensive project where its subdivision is consequently emerging. This is seen by the growing number of terminologies used to define subprojects concerning particular classes of bioactive carbohydrates. Sulfated fucans (SFs) and sulfated galactans (SGs) are relatively new classes of sulfated polysaccharides (SPs) that occur mostly in marine organisms, and exhibit a broad range of medicinal effects. Their structures are taxonomically dependent, and their therapeutic actions include benefits in inflammation, coagulation, thrombosis, angiogenesis, cancer, oxidation, and infections. Some red algae, marine angiosperm and invertebrates express SPs of unique structures composed of regular repeating oligomeric units of well-defined sulfation patterns. This fine pattern of structural regularity is quite rare among any naturally occurring long SPs, and enables accurate structure-biofunction correlations. Seeing that, fucanomics and galactanomics may comprise distinguished glycomics subprojects. We hereby discuss the relevance that justifies the international recognition of these subprojects in the current glycomics age associated with the beneficial outcomes that these glycans may offer in drug development.
Keywords: fucanome; fucanomics; galactanome; galactanomics; glycome; glycomics; sulfated fucan; sulfated galactan fucanome; fucanomics; galactanome; galactanomics; glycome; glycomics; sulfated fucan; sulfated galactan
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Pomin, V.H. Fucanomics and Galactanomics: Marine Distribution, Medicinal Impact, Conceptions, and Challenges. Mar. Drugs 2012, 10, 793-811.

AMA Style

Pomin VH. Fucanomics and Galactanomics: Marine Distribution, Medicinal Impact, Conceptions, and Challenges. Marine Drugs. 2012; 10(4):793-811.

Chicago/Turabian Style

Pomin, Vitor H. 2012. "Fucanomics and Galactanomics: Marine Distribution, Medicinal Impact, Conceptions, and Challenges." Mar. Drugs 10, no. 4: 793-811.


Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert